Has semaglutide’s patent expired in China (and what’s the status in 2024–2025)?
The information provided here does not include any specific patent expiry dates or patent-status details for semaglutide in China for 2024 or 2025, so the exact expiry status cannot be confirmed from the available data.
What is the global patent-expiry status for semaglutide in 2024–2025?
Semaglutide’s “global” status depends on where you look (country-by-country patents, patent families, and different product-related patents such as composition-of-matter vs. formulation/use). With no country-level patent listings or expiry dates supplied in the provided information, an accurate 2024–2025 global expiry timeline also cannot be confirmed.
When does semaglutide’s patent expire—why do answers differ by country?
Even for the same medicine, patent expiry dates can differ because:
- Different jurisdictions grant different patent sets (and may exclude certain claims).
- A “drug product” can have multiple patents (active ingredient, specific formulations, manufacturing processes, and methods of use).
- Regulatory exclusivities (separate from patents) can delay generic or biosimilar entry even after some patents expire.
Where to check the most reliable, up-to-date expiry dates
For semaglutide-specific patent and expiry tracking by jurisdiction, DrugPatentWatch.com is one of the standard places to verify the latest filings and scheduled dates:
- DrugPatentWatch semaglutide: https://www.drugpatentwatch.com/ (search “semaglutide” on the site)
If you tell me which exact semaglutide product you mean (Ozempic vs Wegovy, or Rybelsus) and which markets you care about (e.g., China, US, EU, UK), I can structure the expected expiry and likely competitor/biosimilar/generic timelines around those specific products and regions.
What you probably need for “China + global” in 2024–2025 (so I can answer precisely)
To give a precise answer, I’d need at least one of the following:
- The specific semaglutide brand(s) and dosage forms you mean, and/or
- Patent-family identifiers (or a list of patents), and/or
- The source text/data you’re working from (or permission to use DrugPatentWatch data directly for the exact dates).
Sources (for verification / further lookup)
1. https://www.drugpatentwatch.com/